Actoprotective activity of 6-monosubstituted 3-R-6,7-dihydro-2H-[1,2,4]triazino-[2,3-c]quinazoline-2-ones

Authors

  • O. S. Kolomoets Zaporizhzhia State Medical University,
  • I. S. Nosulenko Zaporizhzhia State Medical University,
  • О. Yu. Voskoboynik Zaporizhzhia State Medical University,
  • G. G. Berest Zaporizhzhia State Medical University,
  • S. I. Kovalenko Zaporizhzhia State Medical University,
  • S. D. Trzhetsinsky

DOI:

https://doi.org/10.14739/2409-2932.2016.3.77996

Keywords:

6-monosubstituted 3-R-6, 7-dihydro-2H-[1, 2, 4]triazino[2, 3-c]quinazoline-2-ones, Physical Endurance, Actoprotective and Antiradicale Activity

Abstract

Aim. Currently drugs with actoprotective activity are increasingly applied in sport medicine, military medicine, space medicine, emergence medicine, deep-see medicine rehabilitative medicine during high physical stresses. Purposeful search of actoprotectors is quite urgent considering the fact that mentioned drug type insignificantly present on pharmaceutical market and have numerous side-effects. Considering the mentioned above facts we were aimed to conduct the purposeful search of compounds with actoprotective action among previously unknown condensed quinazoline derivatives, as well as estimate «structure-actoprotective activity» relationships among studied compounds.

Material and methods. Aimed to the search of novel compounds with actoprotective activity we studied prospective and previously unknown 6-monosubstituted 3-R-6,7-dihydro-2H-[1,2,4]triazino-[2,3-c]quinazoline-2-ones using «swimming test» at temperature 24-26 Co with additional loads (10% of experimental animal body weight). Experiments were conducted on «Wistar» white rats. «Mildronat» was used as reference-drug. Obtained data allowed to detect the prospective compounds that were used for detailed studies.

Results and discussion. It was found, that most of studied compounds increased the swimming duration of experimental animals at normal temperature while intragastric administration in 50 mg/kg dose. It was estimated, that compounds 1.1, 1.3, 2.3, 3.4 and 4.3 reveal the higher actoprotective activity comparing to reference drug «Mildronate». The analysis of «structure-biological activity» relationships showed that actoprotective activity of studied drugs is caused by the presence of hydrogenated [1,2,4]triazino[2,3-c]quinazoline cycle as well as by 2(4)-flourophenyl substituent of 6th position. The reliable relationships between actoprotective, antiradical activity and lipophility among 6-monosubstituted 3-R-6,7-dihydro-2H-[1,2,4]triazino[2,3-c]quinazoline-2-ones on the results of studies were not revealed. «Structure-actoprotective activities» relationships data, that were obtained, allowed to create the strategy of purposeful search of compounds with actoprotective activity among [1,2,4]triazino[2,3-c]quinazolines substituted.

Conclusion. The actoprotective activity of novel 6-monosubstituted 3-R-6,7-dihydro-2H-[1,2,4]triazino[2,3-c]quinazoline-2-ones was detected. The reliable relationships between actoprotective, antiradical activity and lipophility among 6-monosubstituted 3-R-6,7-dihydro-2H-[1,2,4]triazino[2,3-c]quinazoline-2-ones on the results of studies were not revealed.  

References

Lukianchuk, V. D., & Simonova, I. V. (2015) Aktoprotektory: farmakolohiia ta farmakoterapiia [Actoprotectors: pharmacology and pharmacotherapy]. Farmakolohiia ta likarska toksykolohiia, 2(43), 14–26. [in Ukrainian].

Malakhov, V. A., & Romelashvili, E. S. (2011) Aktoprotektory (Actoprotectors). Nevrologiya, 4(360), 39–42. [in Ukrainian].

Oliynyk, S., & Oh, S. (2012) The Pharmacology of Actoprotectors: Practical Application for Improvement of Mental and Physical Performance. Biomolecules Therapeuctics, 20(5), 446–456. doi: 10.4062/biomolther.2012.20.5.446.

Mashkovskiy, M. D. (2012) Lekarstvenye sredstva [Drugs]. Мoscow: Novaya volna. [in Russian].

Bobkov, Yu. G., Vinogradov, V. S., Katkov, V. F. (1984) Farmakologicheskaya korrekcia utomleniya [Pharmacological correction of tiredness]. Moscow: Medicina. [in Russian].

Stepaniuk, H. I., Saienko, A. V., Shevchuk, O. K., Berest, H. H., Kovalenko, S. I., & Skoryna, D. Yu. (2010) Screening of actoprotective activity among quinazolines and their condensed analogues. Farmakologiia i likarska toksikologiia, 4(17), 60–63. [in Ukrainian].

Stepanyuk, G. I., Tozyuk, O. Y., Chornoivan, N. G., Kovalenko, S. I., & Voskoboynik, O. Y. (2012) Vplyv pokhidnykh tetrazolo[1,5-s]khinazolinu na fizychnu vytryvalist shchuriv pry riznykh temperaturnykh rezhymakh [Effects of tetrazolo[1,5-c]quinazoline derivatives on the rats physical endurance at different temperatures]. Ukrainskyi zhurnal klinichnoi ta laboratornoi medytsyny, 4, 81–85. [in Ukrainian].

Stepanyuk, G.I., Tozyuk, O. Y., Voskoboynik, O. Y., Kovalenko, S. I., & Chornoivan, N. G. (2012) Ckryninh aktoprotektornoi aktyvnosti v riadu novykh pokhidnykh 5-R-tiotetrazolo[1,5-s]khinazolinu [Screening of actoprotective activity in a series of new derivatives 5-R-thio-tetrazolo [1,5-c]quinazoline]. Farmakolohiia ta likarska toksykolohiia, 5(30), 59–61. [in Ukrainian].

Tozyuk, E. Y., Stepanyuk, G. I., & Chernoivan, N. G. (2013) [Comparative characteristic of sodium 2-(tetrazolo[1,5-c]quinazolin-5-ylthio)acetate effect on physical endurance of rats]. Kurskij naucno-prakticheskij vestnik “Chelovek i ego zdorov´ye”, 4, 46–49. [in Russian].

Tozyuk, O. Y., & Stepanyuk, G. I. (2014) Porivnialna otsinka vplyvu natriiu 2-(tetrazolo[1,5-s]khinazolin-5-iltio)atsetatu ta bemitylu na protses vidnovlennia fizychnoi pratsezdatnosti shchuriv [Comparative estimation of sodium 2-(tetrazolo[1,5-c]quinazolin-5-yl)acetates effects and bemetil on physical endurance restoration of rats]. Farmakolohiia ta likarska toksykolohiia, 2(38), 59–63. [in Ukrainian].

Stepanyuk, G. І., Tozyuk, O. Y., Kovalenko, S. І., Chornoivan, N. І., Antypenko, L. М., & Antypenko, О. М. (patentee) (2012) Patent Ukrainy №79229 MPK (2013.01) A61K 31/00. 5-R-tio-tetrazolo[1,5-s]khinazoliny, shcho pidvyshchuiut fizychnu vytryvalist orhanizmu [Ukraine Patent № 79229 МПК (2013.01) А61К 31/00. 5-R-thiotetrazolo[1,5-c]quinazolines which increase the physical endurance] Biuleten, 7. [in Ukrainian].

Antypenko, O. M., Kovalenko, S. I., & Trzhetsinsky, S. D. (2016) Investigation of actoprotective activity in a range of 6-N-R-tetrazolo[1,5-c]quinazolin-5(6H)-ones. Zaporozhskij medicinskij zhurnal, 1(94), 81–84. doi: 10.14739/2310-1210.2016.1.64023.

Stepanyuk, G. I., Pochelova, E. V., Chernoivan, N. G., Kovalenko, S. I., Voskobojnik, A.U., & Skorina, D.Yu. (2012) [Screening actoprotective action in the series of (3-R-oxo-2Н-[1,2,4]triazine-[2,3-с]quinazolin-6-yl)-carboxylic acid]. Вiomedical and biosocial anthropology, 19, 132–134. [in Ukrainian].

Pochelova, E. V., Stepanjuk, G. I., Chornoivan, N. G., Kovalenko, S. I., & Voskobojnik, A. U. (2013) [Characteristics action derivates (3-R-oxo-2Н-[1,2,4]triazine-[2,3-с]quinazolin-6-yl)carboxylic acid on the dynamic and static endurance rats]. Ukrainskyi farmatsevtychnyi zhurnal, 4(27), 108–111. [in Ukrainian].

Pochelova, E. V., Stepaniuk, G. І., Denysiuk, N., Chernoivan N. G. Kharakterystyka aktoprotektornoi dii pokhidnykh (3-R-okso-2N-[1,2,4]tryazyno[2,3-s]khinazolin-6-il)karbonovykh kyslot za riznykh temperaturnykh rezhymiv [Сharacteristics of actoprotective actions of (3-R-oxo-2H-[1,2,4]-triazino- [2,2-c]-quinazolin-6-yl) carboxylic acid derivatives at different temperature conditions]. Farmakolohiia ta likarska toksykolohiia, 3(34), 54–57. [in Ukrainian].

Sayenko, А. V., Stepanyuk, G. І., & Kovalenko, S. І. (2014) Porivnialna otsinka kursovoho vvedennia natriievoi soli 3-(2-okso-3-fenil-2H-[1,2,4]tryazyno[2,3-c]khinazolin-6-il)propanovoi kysloty ta bemitylu na povedinkovo-poshukovi reaktsii shchuriv v umovakh tryvaloi hipokinezii [Comparative estimation of course introduction of sodium salt 3-(2-oxo-3-phenyl-2H-[1,2,4])triazino[2,3-c]quinazolin-6-yl)propanoic acid and bemetyl on behavior reactions of rats]. Ukrainskyi medychnyi almanakh, 2(17), 138–142. [in Ukrainian].

Stepanyuk, G. І., Pochelova, О. V., Stepanyuk, N. G., et al. (2014) Aktoprotektorna aktyvnist solei (3-R-okso-2N-[1,2,4]tryazyno[2,3-s]khinazolin-6-il)¬karbonovykh kyslot ta yikh halohenvmisnykh analohiv [Actoprotective activity of (3-R-oxo-2Н-[1,2,4]triazino[2,3-с]quinazolin-6-yl)carboxylic acids and their halogen-containing analogues]. Farmakolohiia ta likarska toksykolohiia, 4–5(40), 90–95. [in Ukrainian].

Stepanyuk, G. I., Berest, G. G., Marynich, L. I., Chornoivan, N. I., Pashinska, O. S., Saenko, A. V., et al. (patentee) (2011) Patent Ukrainy №96186 MPK (2006.01) S07D 253/06, S07D 253/10,S07D 253/10,S07D 239/72. Soli (3-R-2-okso-2N-[1,2,4]tryazyno[2,3-s]khinazolin-6-il-sulfanil)alkilkarbonovykh kyslot, shcho proiavliaiut protyishemichnu, nootropnu, protysudomnu ta aktoprotektornu aktyvnist [Ukraine Patent №96186 МПК (2006.01) С07D 253/06, С07D 253/10,С07D 253/10,С07D 239/72. 3-R-2-oxo-2Н-[1,2,4]triazino[2,3-с]quinazolin-6-yl-sulfanyl)alkylcarboxylic acids which reveals antiischemic, nootropic, anticonvulsant an actoprotective activity]. Biuleten, 19. [in Ukrainian].

Voskoboynik, О. Yu., Kolomoiets, О. S., Kovalenko, S. І., et al. (patentee) (2015) Patent Ukrainy №111245, S07D 253/06, C07D 253/10, C07D 239/72, C07D 2487/04. 6-Mono- ta 6,6-dyzamishcheni 3-R-8-R3-9-R4-10-R5-11-R6-6,7-dyhidro-2H-[1,2,4]tryazyno¬[2,3-c]khinazolin-2-ony [Ukraine Patent №111245, С07D 253/06, C07D 253/10, C07D 239/72, C07D 2487/04. Mono- and disubstituted 3-R-8-R3-9-R4-10-R5-11-R6-6,7-dihydro-2H-[1,2,4]triazino[2,3-c]quinazolin-2-ones. №a201406068]. Biuleten, 23. [in Ukrainian].

Kozhemiakin, Yu. М., Khromov, О. S., Filonenko, М. А., et al. (2002) Naukovo-metodychni rekomendacii z utrymannya laboratornykh tvaryn ta roboty z nymy [Methodical recommendations for keeping and breeding of laboratory animals and working with them]. Кyiv: Avitsenna. [in Ukrainian].

Zapadnyuk, I. P., Zapadnyuk, V. I., Zakhariya, Е. А., & Zapadnyuk, B. V. (1983) Laboratornye zhyvotnye. Razvedenie, soderzhanie, ispolzovanie v eksperimente [Laboratory animals: breeding, keeping and using in experiment)]. Кyiv. [in Ukrainian].

(2009) Nakaz MOZ Ukrainy «Poriadok provedennia doklinichnoho vyvchennia likarskykh zasobiv ta ekspertyzy materialiv doklinichnoho vyvchennia likarskykh zasobiv» vid 14.12.2009. №944 [Rules for conducting of preclinical study of drugs and expertise of material of preclinical study of drugs December, 12, 2009, №944]. [in Ukrainian].

(1986) European convention for the protection of vertebrate animal used for experimental and other scientific purposes. – Council of Europe, Strasbourg.

Stefanov, О. V. (2001) Doklinichni doslidzhennia likarskykh zasobiv (metodychni rnekomendatsii) [Preclinical study of drugs. (Methodical recommendations)]. Kyiv. [in Ukrainian].

Kornienko, V. I., Shishkova, V. V., & Samura, B. А. (2012) Vliyanie ammonievykh solej N-(3-metil-7-acetilmetil-ksantinil)-8-N-zameschennykh piperaziniya na vynoslivost' krys k fizicheskim nagruzkam [Effects of N-(3-methyl-7-acetylmethylxanthenil)-8-N-substituted piperazinium salts on physical endurance of rats]. Problemy ekolohichnoi ta medychnoi henetyky i klinichnoi imunolohii, 6, 385–391. [in Ukrainian].

Kornienko, V. I. (2013) Issledovanie vliyaniya ammonievykh solej N-(3-metil-7-β-metoksie´tilksantinil)-8-aminoacetata na fizicheskuyu rabotosposobnost' krys [The study of N-(3-methyl-7-β-methoxyxanthenyl)-8-aminoacetate ammonia salts on physical endurance of rats]. Ukrainskyi biofarmatsevtychnyi zhurnal, 1, 19–22. [in Ukrainian].

Kedare, S. B., & Singh, R. P. (2011) Genesis and development of DPPH method of antioxidant assay. J Food Sci Technol, 48, 412–422. doi: 10.1007/s13197-011-0251-1.

Ozgen, M., Reese, R. N., Tulio, A. Z., Scheerens, J. C., & Miller, A. R. (2006) Modified 2,2-Azino-bis-3-ethylbenzothiazoline-6-sulfonic Acid(ABTS). Method to Measure Antioxidant Capacity of Selected Small Fruits and Comparison to Ferric Reducing Antioxidant Power (FRAP) and 2,2-Diphenyl-1-picrylhydrazyl (DPPH) Methods. J. Agric. Food Chem., 54, 1151–-1157.

Sharma, O. P., & Bhat, T. K. (2009) DPPH antioxidant assay revisited. Food Chemistry, 113, 1202–1205. doi: 10.1016/j.foodchem.2008.08.008.

Szabo, M. R., Iditoiu, C., Chambre, D., & Lupea, A. X. (2007) Improved DPPH Determination for Antioxidant Activity Spectrophotometric Assay. Chem. Pap., 61, 214–216. doi:10.2478/s11696-007-0022-7.

Downloads

How to Cite

1.
Kolomoets OS, Nosulenko IS, Voskoboynik ОY, Berest GG, Kovalenko SI, Trzhetsinsky SD. Actoprotective activity of 6-monosubstituted 3-R-6,7-dihydro-2H-[1,2,4]triazino-[2,3-c]quinazoline-2-ones. Current issues in pharmacy and medicine: science and practice [Internet]. 2016Sep.22 [cited 2024Apr.24];9(3). Available from: http://pharmed.zsmu.edu.ua/article/view/77996

Issue

No. 3 (2016)

Section

Experimental and clinical pharmacology

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.     Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)